ASK REDCHAT ANYTHING ABOUT ATARA BIOTHERAPEUTICS INC.
Atara Biotherapeutics Inc. (NASDAQ: ATRA)
Listen to this Section
$9.96
-0.3150
(
-3.07% )
23.1K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| ATA188DetailsEpstein-Barr virus, Multiple sclerosis |
Phase 2 |
| ATA3219DetailsSystemic lupus erythematosus, Lupus nephritis, Autoimmune disease |
Phase 1 |
| ATA3219DetailsNon-Hodgkin lymphoma, Blood cancer, Cancer |
Phase 1 |
| ATA188DetailsMultiple sclerosis, Epstein-Barr virus |
Failed |
Market Data
|
| Open |
$9.96 |
| Previous Close |
$10.27 |
| Volume |
23.1K |
| Market Cap |
$86.77M |
| Day Range |
$9.84 - $10.47 |
| 52 Week Range |
$3.92 - $19.15 |
| Shares Outstanding |
9.01M |
| Change % |
-3.07% |
| Net Change |
▼ -0.3150 |
| Insider Ownership |
-0.01% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| IPO Year | 2014 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-3,685,812.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2025-08-19 |
Buy |
55000.00 |
Panacea Innovation Ltd |
| 2025-07-21 |
Buy |
19335.00 |
Panacea Innovation Ltd |
| 2024-08-14 |
Sale |
-9000.00 |
Touchon Pascal |
| 2024-05-20 |
Sale |
-81506.00 |
Touchon Pascal |
| 2024-05-20 |
Sale |
-25750.00 |
Henrich Jill |
| 2024-05-20 |
Sale |
-28648.00 |
Hyllengren Eric J |
| 2024-05-20 |
Sale |
-32401.00 |
Murugan Amar |
| 2024-05-20 |
Sale |
-42899.00 |
Nguyen AnhCo |
| 2024-04-02 |
Sale |
-150000.00 |
Gallagher Carol Giltner |
| 2024-04-02 |
Sale |
-150000.00 |
Roncarolo Maria Grazia |